WHO Functional ClassOpen-label Extension Study AC-052-353

Class I (n)

Class II

Class III

Class IV

0

0

29

0

1

12

15

1

1

11

16

1

Start of AC-052-351

6 months

1 year

Open-label bosentan

WHO class

29 patients entered the open-label study

9045.01

Previous slide

Next slide

Back to first slide

View graphic version